Patents
-
{
- All
- News
- Videos
-
Sony Patents Controller With Buttons That Change Hardness In Real-Time
Sony patents a controller with buttons that change hardness using magneto-viscoelastic elastomer.
-
ICMR Launches India's Largest Biomedical Technology Transfer Platform
ICMR's launch of the Medical Innovations Patent Mitra platform marks an important moment for India's biomedical sector.
-
ICMR Launches India's Largest Biomedical Technology Transfer Platform
ICMR's launch of the Medical Innovations Patent Mitra platform marks an important moment for India's biomedical sector.
-
Honda ADV 160 Design Patented In India, Will Rival Yamaha Aerox, Hero Xoom 160
Honda Motorcycle and Scooter India has patented the Honda ADV 160 in India, hinting at a possible launch against the Yamaha Aerox 155 and Hero Xoom 160.
-
Samsung Patent Document Hints at Galaxy Smartphone With Expanding Display, Movable Camera System
Samsung has been rumoured to be exploring smartphones beyond traditional form factors. Following its success with the book-style and clamshell-design handsets in recent years, leaks have indicated that it is also developing a wide foldable, widely known as the Galaxy Z Fold Wide. A newly discovered patent now suggests that the South Korean technolo...
-
Samsung Patent Hints at Triple-Folding Galaxy Z TriFold Wide With Broader Display
Samsung is speculated to be working on a new foldable smartphone form factor, with a recently surfaced patent hinting at a tri-fold design. The development comes as the company is expected to expand its foldable portfolio following the introduction of the Galaxy Z Tri-Fold in 2025. The patent suggests Samsung may be working on a more experimental f...
-
Chery Tiggo 7L Design Patented in India; Mahindra XUV 7XO's New Rival Incoming
Patented in India soon after its China debut, the Chery Tiggo 7L could soon challenge the Mahindra XUV 7XO with its launch in the Indian market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Sony Patents Controller With Buttons That Change Hardness In Real-Time
Sony patents a controller with buttons that change hardness using magneto-viscoelastic elastomer.
-
ICMR Launches India's Largest Biomedical Technology Transfer Platform
ICMR's launch of the Medical Innovations Patent Mitra platform marks an important moment for India's biomedical sector.
-
ICMR Launches India's Largest Biomedical Technology Transfer Platform
ICMR's launch of the Medical Innovations Patent Mitra platform marks an important moment for India's biomedical sector.
-
Honda ADV 160 Design Patented In India, Will Rival Yamaha Aerox, Hero Xoom 160
Honda Motorcycle and Scooter India has patented the Honda ADV 160 in India, hinting at a possible launch against the Yamaha Aerox 155 and Hero Xoom 160.
-
Samsung Patent Document Hints at Galaxy Smartphone With Expanding Display, Movable Camera System
Samsung has been rumoured to be exploring smartphones beyond traditional form factors. Following its success with the book-style and clamshell-design handsets in recent years, leaks have indicated that it is also developing a wide foldable, widely known as the Galaxy Z Fold Wide. A newly discovered patent now suggests that the South Korean technolo...
-
Samsung Patent Hints at Triple-Folding Galaxy Z TriFold Wide With Broader Display
Samsung is speculated to be working on a new foldable smartphone form factor, with a recently surfaced patent hinting at a tri-fold design. The development comes as the company is expected to expand its foldable portfolio following the introduction of the Galaxy Z Tri-Fold in 2025. The patent suggests Samsung may be working on a more experimental f...
-
Chery Tiggo 7L Design Patented in India; Mahindra XUV 7XO's New Rival Incoming
Patented in India soon after its China debut, the Chery Tiggo 7L could soon challenge the Mahindra XUV 7XO with its launch in the Indian market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
